|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/55 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3050885 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16152464.0 |
| Europos patento paraiškos padavimo data | 2010-11-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0919433 | 2009-11-05 | GB | |
| 201010509 | 2010-06-22 | GB | |
| PCT/EP2010/0615 | 2010-08-06 | WO | |
| 201014231 | 2010-08-25 | GB |
| (72) |
BAILEY, James, GB
GOSMINI, Romain Luc Marie, FR
MIRGUET, Olivier, FR
WITHERINGTON, Jason, GB
|
| (73) |
GlaxoSmithKline LLC,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
| (54) | BENZODIAZEPINE BROMODOMAIN INHIBITOR |
| BENZODIAZEPINE BROMODOMAIN INHIBITOR |